Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart shoe tracks Parkinson's gait and may help with walking

NCT ID NCT06975059

Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused This study
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This study is testing a special shoe called NUSHU that has sensors to measure how people with Parkinson's disease walk and keep their balance. The shoe can also give small vibrations to possibly help with walking problems. Researchers will compare results from people with early, moderate, and advanced Parkinson's, as well as healthy volunteers, to see if the shoe is comfortable and easy to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Jul 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Parkinson's Disease: Inclusion Criteria: 1. Male or female ≥ 18 years of age. 2. A diagnosis of Parkinson's disease 3. Able to give written informed consent (as determined by the investigator) 4. Can converse in English and read and perform all study activities 5. Has willingness and ability to comply with study requirements Exclusion Criteria: 1. Diagnosis of an atypical parkinsonism syndrome, drug-induced parkinsonism, essential tremor, or other diagnoses that explain movement symptoms other than PD 2. A diagnosis of significant CNS disease other than PD such as stroke, multiple sclerosis, epilepsy 3. Persons with disorders other than PD significantly affecting gait as determined by the investigator 4. History of MRI brain scan indicative of clinically significant abnormality as determined by the investigator 5. Inability to wear interventional device 6. Unable to ambulate independently at least with assistive walking device but without additional person assistance 7. Pregnant or planning pregnancy within study timeframe 8. Montreal Cognitive Assessment (MoCA) score \< 22 at screening 9. Resides in a nursing home or assisted care facility Healthy Controls: Inclusion Criteria: 1. Male or female ≥ 18 years of age. 2. No neurological disease or other significant gait impairment as deemed by the study investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson&#39;S disease (PD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson&#39;S disease (PD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Weill Cornell

    New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.